AMRN Q2 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$53M+16.4% YoY

Gross Profit

$40M75.6% margin

Operating Income

-$32M-61.4% margin

Net Income

-$34M-65.0% margin

EPS (Diluted)

$-2.33

QoQ Revenue Growth

+19.9%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$204M

Total Liabilities

$251M

Stockholders' Equity

-$47M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$45M	+16.4%
Gross Profit	$40M	$34M	+17.6%
Operating Income	-$32M	-$11M	-183.4%
Net Income	-$34M	-$14M	-150.9%

Revenue Segments

Product

$53M100%

License

$106,0000%